Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RACE 3 upstream rhythm control in early atrial fibrillation with heart failure
2009-011291-29Phase 4Unknown
- Sponsor
- Netherlands Heart Institute
- Start
- Aug 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eplerenone, spironolactone, atorvastatin, fluvastatin, pravastatin and 2 more in Atrial fibrillation (AFib) and heart failure (HF) (2 arms), sponsored by Netherlands Heart Institute. Primary endpoint: Sinus rhythm after 1 year. Status: unknown.
02
Drugs
eplerenonespironolactoneatorvastatinfluvastatinpravastatin
03
Conditions
Atrial fibrillation (AFib)heart failure (HF)
Beyond the preview
Go deeper on 2009-011291-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011291-29.